Z/Yen: Clinical Trial Records Move To Blockchain

299
ADVERTISEMENTS Cryptofinancing

Share with:


The Computerised Life Events Assessment Record (CLEAR) project announced that it has begun recording information relevant to clinical trials on the MetroGnomo mutual distributed ledger (aka Blockchain). The CLEAR project – led by Professor Antonia Bifulco – is developing an interactive online method for measuring stress based on life changes, events and ongoing difficulties. The distributed ledger is a development of Z/Yen’s metrognomo.com open-source timestamp service.

MetroGnomo provides an unchangeable authoritative record of trials data. Proof that a given piece of information exists is logged by a network of receivers to guarantee persistence and incorruptibility without revealing the information itself. Channel Island government, the States of Alderney, have agreed to operate a receiver until 2021 and to oversee MetroGnomo’s integrity.

Bob McDowall, Chairman of the Policy Finance Committee of the States of Alderney, noted:

“Logging and recoding clinical trials as a publicly available record is a very tangible evidence of the dynamic but simple uses of distributed ledgers.”

The use of a distributed ledger allows scientific studies to benefit from more transparent data collection. Advanced applications utilize public-private key cryptography to grant access to the underlying data. Smart contracts can facilitate time or use limited access and revocability.

Professor Antonia Bifulco, CLEAR Principal Investigator, elaborated:

“Whilst distributed ledgers facilitate robust records worthy of trust, they also provide a straightforward channel to distribute operational data. This removes the need to grant external staff or auditors with access to sensitive onsite systems.”

Executive Chairman Professor Michael Mainelli stated:

“Z/Yen is actively working with a number of other parties within the clinical trials and medical records space. Future developments include health information, such as patient prescriptions, scans and medical passports.”

MetroGnomo is handling over 20,000 clinical interactions each working day.

About Richard Kastelein

Richard Kastelein is the Founder, Publisher and Editor in Chief of industry leading online publication, Blockchain News, partner of token design and ICO architecture company Cryptoassets Design Group and co-founder and director at education company Blockchain Partners.

As a prominent keynote presenter, Kastelein has spoken on Blockchain at events in Gdansk, Beijing, Venice, Nanchang, Shanghai, Amsterdam, Minsk, Dubai, Antwerp, Eindhoven, Bucharest, Munich, Nairobi, Tel Aviv, Manchester, Brussels, Barcelona, San Meteo etc, where he helped spread the cause for Blockchain technology and cryptocurrency and, consequently, has built a notable network in the scene.

Visit Website
View All Articles
advertisement